A new wave of "multi-cancer" blood tests is heading to select GP surgeries in a trial initiative aimed at catching hard-to-diagnose malignancies much sooner.
The targeted rollout focuses on identifying elusive abdominal conditions at an earlier stage, specifically including liver, ovarian, and pancreatic cancers. By integrating these screenings into primary care settings, health providers hope to streamline detection before symptoms become advanced.
Further details regarding the exact rollout schedule and participating practices are expected as the implementation phases progress.
